Skip to main content

Table 3 Tumors’ characteristics

From: Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study

 

Stomach

Duodenum

Jejunum

Ileum

Colon

Appendix

Rectum

Pancreas

Total

 

n = 16

n = 9

n = 1

n = 4

n = 8

n = 8

n = 99

n = 23

N = 168 (%)

Size

         

<1 cm

2

0

0

0

1

0

39

2

44 (26.19)

1-2 cm

1

4

0

2

1

3

31

8

50 (29.76)

>2 cm

9

5

1

2

5

1

15

13

51 (30.36)

Unclear

4

0

0

0

1

4

14

0

23 (13.69)

Stage

         

T1N0M0

4

0

0

0

1

2

43

5

55 (32.74)

T2N0M0

1

3

0

0

0

1

17

5

27 (16.07)

T3N0M0

2

1

0

1

2

4

2

7

19 (11.31)

T4N0M0

1

2

0

0

0

0

0

4

7 (4.17)

TanyN1M0

5

1

1

3

3

0

10

1

24 (14.29)

TanyNanyM1

2

2

0

0

2

1

6

1

14 (7.74)

Unclear

1

0

0

0

0

0

21

0

22 (13.69)

WHO 2010

        

NET/G1

0

2

0

0

1

0

26

5

34 (20.23)

NET/G2

0

1

0

0

1

0

3

2

7 (4.17)

NEC/G3

1

0

0

0

2

0

4

5

12 (7.14)

Unclear

15

6

1

4

4

8

66

11

115 (68.45)

WHO 2000

        

WDET

0

2

1

0

0

0

5

4

12 (7.14)

WDEC

0

2

0

0

0

0

5

0

7 (4.17)

PDEC

1

2

0

0

0

0

4

6

13 (7.74)

Unclear

15

3

0

4

8

8

85

13

136 (80.95)

  1. TNM: tumor-node-metastasis approach [11]; NET, neuroendocrine tumor; NEC, neuroendocrine carcinoma; G1, grade 1; G2, grade 2; G3, grade 3; WDET, well differentiated endocrine tumour; WDEC, well differentiated endocrine carcinoma; PDEC, poorly differentiated endocrine carcinoma.